Search Results - "Jones, Brett D.M."

High reactivity of the cortisol awakening response predicts positive treatment outcome in heterogeneous depressed patients completing an alternate milieu inpatient program by Jones, Brett D.M., M.Sc, Chopra, Kevin K., M.D., Ph.D, Grummitt, Jessica, B.Sc, Ravindran, Arun, M.B.B.S., Ph.D, Matthews, Stephen G., Ph.D, Levitan, Robert D., M.D., M.Sc

“…Abstract Objective Delineating clinically meaningful subgroups within heterogeneous depressed populations is a major challenge. As outlined in the Research…”
Get full text

Attachment style at discharge predicts depression status four months following a 28-day alternate-milieu inpatient program by Jones, Brett D.M, Chopra, Kevin K, Grummitt, Jessica, Ravindran, Arun, Levitan, Robert D

Get full text

Neural effects of psychedelics: Complexity the key word by Jones, Brett D M, Husain, M Ishrat

Get full text

Treatment outcomes in major depressive disorder in patients with comorbid alcohol use disorder: A STARD analysis by Tang, Victor M., Yu, Dengdeng, Weissman, Cory R., Jones, Brett D.M., Wang, Guan, Sloan, Matthew E., Blumberger, Daniel M., Daskalakis, Zafiris J., Le Foll, Bernard, Voineskos, Daphne

“…Guidance on Major Depressive Disorder (MDD) treatment in those with comorbid Alcohol Use Disorder (AUD) is limited. We performed a secondary analysis on the…”
Get full text

The effect of weighted blankets on sleep quality and mental health symptoms in people with psychiatric disorders in inpatient and outpatient settings: A systematic review and meta-analysis by Wong, Stanley, Fabiano, Nicholas, Luu, Brandon, Seo, Chanhee, Gupta, Arnav, Kim, Helena K., Shorr, Risa, Jones, Brett D.M., Mak, Michael S.B., Husain, M. Ishrat

“…There is limited synthesized evidence for weighted blankets usage in psychiatric patients. We performed a PRISMA compliant systematic review and meta-analysis…”
Get full text

Prescribed psychostimulants and other pro‐cognitive medications in bipolar disorder: A systematic review and meta‐analysis of recurrence of manic symptoms by Chiorean, Andreea, Jones, Brett D. M., Murong, Mijia, Gonzalez‐Torres, Christina, Kloiber, Stefan, Ortiz, Abigail, Rosenblat, Joshua D., Mulsant, Benoit H., Husain, M. Ishrat

“…Objectives Clinicians are often hesitant to prescribe psychostimulants in bipolar disorder (BD) due to concerns of inducing (hypo)mania, despite limited…”
Get full text

Relative effectiveness of augmentation treatments for treatment-resistant depression: a systematic review and network meta-analysis by Carter, Ben, Strawbridge, Rebecca, Husain, Muhammad Ishrat, Jones, Brett D. M., Short, Roxanna, Cleare, Anthony J., Tsapekos, Dimosthenis, Patrick, Fiona, Marwood, Lindsey, Taylor, Rachael W., Mantingh, Tim, de Angel, Valeria, Nikolova, Viktoriya L., Carvalho, Andre F., Young, Allan H.

“…Most interventions for treatment-resistant depression (TRD) are added as augmenters. We aimed to determine the relative effectiveness of augmentation…”
Get full text

Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders by Wong, Stanley, Yu, An Yi, Fabiano, Nicholas, Finkelstein, Ofer, Pasricha, Aryan, Jones, Brett D.M., Rosenblat, Joshua D., Blumberger, Daniel M., Mulsant, Benoit H., Husain, M. Ishrat

“…There has been a resurgence of interest in the use of psychedelic therapies for several mental and substance use disorders. Psilocybin, a "classic"…”
Get full text

The meaningful change threshold as measured by the 16-item quick inventory of depressive symptomatology in adults with treatment-resistant major depressive and bipolar disorder receiving intravenous ketamine by McIntyre, Roger S., Lipsitz, Orly, Lui, Leanna M.W., Rodrigues, Nelson B., Gill, Hartej, Nasri, Flora, Ling, Rui, Teopiz, Kayla M., Ho, Roger C., Subramaniapillai, Mehala, Kratiuk, Kevin, Mansur, Rodrigo B., Jones, Brett D.M., Lee, Yena, Rosenblat, Joshua D.

“…•A meaningful change threshold (MCT) is needed to characterize patient-reported outcomes (PROs) in individuals with treatment-resistant depression (TRD).•A…”
Get full text

The use of sequential pharmacotherapy for the treatment of acute major depression: a scoping review by Jones, Brett D M, Husain, M Ishrat, Mulsant, Benoit H

“…Major Depressive Disorder (MDD) is a chronic, relapsing, and remitting disorder affecting over 250 million persons each year worldwide. More than 50% of the…”
Get more information

Frequency analysis of symptomatic worsening following ketamine infusions for treatment resistant depression in a real-world sample: Results from the canadian rapid treatment center of excellence by Di Vincenzo, Joshua D., Lipsitz, Orly, Rodrigues, Nelson B., Jones, Brett D.M., Gill, Hartej, Lee, Yena, Lui, Leanna M.W., Teopiz, Kayla M., Ho, Roger, Lin, Kangguang, Nasri, Flora, McIntyre, Roger S., Rosenblat, Joshua D.

“…Antidepressants are associated with symptomatic worsening in a subgroup of patients. Replicated evidence has demonstrated rapid and robust antidepressant…”
Get full text

Associations between peripheral inflammation and clinical phenotypes of bipolar depression in a lower-middle income country by Jones, Brett D.M., Mahmood, Urbee, Hodsoll, John, Chaudhry, Imran B., Khoso, Ameer B., Husain, Mohammed O., Ortiz, Abigail, Husain, Nusrat, Mulsant, Benoit H., Young, Allan H., Husain, Muhammad I.

“…There has been increased interest in repurposing anti-inflammatories for the treatment of bipolar depression. Evidence from high-income countries suggests that…”
Get full text

Boxing as an Intervention in Mental Health: A Scoping Review by Bozdarov, Johny, Jones, Brett D. M., Daskalakis, Zafiris J., Husain, M. Ishrat

“…Introduction: Physical activity has been shown to have a multitude of mental health benefits. However, there is limited evidence on the specific mental health…”
Get full text

Magnitude of the Placebo Response Across Treatment Modalities Used for Treatment-Resistant Depression in Adults: A Systematic Review and Meta-analysis by Jones, Brett D M, Razza, Lais B, Weissman, Cory R, Karbi, Jewel, Vine, Tya, Mulsant, Louise S, Brunoni, Andre R, Husain, M Ishrat, Mulsant, Benoit H, Blumberger, Daniel M, Daskalakis, Zafiris J

“…The placebo effect in depression clinical trials is a substantial factor associated with failure to establish efficacy of novel and repurposed treatments…”
Get full text

Metabolic function in patients with bipolar depression receiving anti-inflammatory agents: Findings from the MINDCARE study, a multicentre, randomised controlled trial by Kloiber, Stefan, Jones, Brett D.M., Hodsoll, John, Chaudhry, Imran B., Khoso, Ameer B., Husain, M. Omair, Ortiz, Abigail, Goldstein, Benjamin I., Husain, Nusrat, Mulsant, Benoit H., Young, Allan H., Husain, M. Ishrat

“…•Exploration of metabolic variables in a sample of depressed bipolar patients in Pakistan.•Low BMI and WC were associated with higher depression…”
Get full text

Metabolic variables associated with response to cognitive behavioural therapy for depression in females: A Canadian biomarker integration network for depression (CAN-BIND) study by Jones, Brett D.M., Levitan, Robert D., Wang, Wei, Uher, Rudolf, Rotzinger, Susan, Foster, Jane A., Kennedy, Sidney H., Farzan, Faranak, Quilty, Lena C., Kloiber, Stefan

“…Cognitive behavioural therapy (CBT) is an established first-line treatment for depression; however, it remains unclear which factors predict a positive outcome…”
Get full text

Inflammation as a treatment target in mood disorders: review by Jones, Brett D M, Daskalakis, Zafiris J, Carvalho, Andre F, Strawbridge, Rebecca, Young, Allan H, Mulsant, Benoit H, Husain, M Ishrat

“…Mood disorders, i.e. major depressive disorder (MDD) and bipolar disorders, are leading sources of disability worldwide. Currently available treatments do not…”
Get full text

Repurposing Anti-inflammatory Agents for Mood Disorders: an Updated Review of Current Evidence by Kittur, Mary E., Jones, Brett D. M., Dai, Nasia, Mahboob, Mariam, Husain, Muhammad I.

“…Purpose of Review To provide an updated summary on the field of immunopsychiatry as it pertains to clinical and therapeutic translation in mood disorders…”
Get full text

Astrocytes in the Neuropathology of Bipolar Disorder: Review of Current Evidence by Dai, Nasia, Jones, Brett D. M., Husain, Muhammad Ishrat

“…(1) Background: Approximately one-third of patients with bipolar disorder (BD) do not experience sustained remission with current treatments. Presently,…”
Get full text

Targeting Metabolic Dysfunction for the Treatment of Mood Disorders: Review of the Evidence by Jones, Brett D M, Farooqui, Salman, Kloiber, Stefan, Husain, Muhammad Omair, Mulsant, Benoit H, Husain, Muhammad Ishrat

“…Major depressive disorder (MDD) and bipolar disorder (BD) are often chronic with many patients not responding to available treatments. As these mood disorders…”
Get full text